成人先天性心脏病：COVID-19及疫苗分配/优先排序的特殊考量
Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization.
作者信息
Sabatino Jolanda, Di Salvo Giovanni, Calcaterra Giuseppe, Bassareo Pier Paolo, Oreto Lilia, Cazzoli Ilaria, Calabrò Maria Pia, Guccione Paolo, Gatzoulis Michael A
机构信息
Division of Paediatric Cardiology, Department of Women's and Children's Health, University of Padua, Padua, Italy.
Division of Cardiology, "Magna Graecia" University, Catanzaro, Italy.
出版信息
Int J Cardiol Congenit Heart Dis. 2021 Aug;4:100186. doi: 10.1016/j.ijcchd.2021.100186. Epub 2021 Jun 16.
Abstract
Individuals with the highest risk for adverse outcomes of COVID-19 should be prioritized by the vaccine allocation policies. We have conducted a literature review of published studies, which comprehend congenital heart disease (CHD) and COVID-19, in order to present the overall evidences of both exposure and clinical risk of patients with adult congenital heart disease (ACHD) and to propose a risk profile schema for those patients to be incorporated into vaccine distribution decisions.
摘要
新冠病毒病（COVID-19）不良结局风险最高的个体应在疫苗分配政策中被优先考虑。我们对已发表的关于先天性心脏病（CHD）与COVID-19的研究进行了文献综述，以便呈现成人先天性心脏病（ACHD）患者暴露情况及临床风险的总体证据，并为这些患者提出一个风险概况模式，以纳入疫苗分配决策。
相似文献
1
Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization.成人先天性心脏病：COVID-19及疫苗分配/优先排序的特殊考量
Int J Cardiol Congenit Heart Dis. 2021 Aug;4:100186. doi: 10.1016/j.ijcchd.2021.100186. Epub 2021 Jun 16.
2
COVID-19 vaccination in adults with congenital heart disease: Real-world data from an Italian tertiary centre.先天性心脏病成人的新冠病毒疫苗接种：来自意大利一家三级中心的真实世界数据。
Int J Cardiol Congenit Heart Dis. 2021 Dec;6:100266. doi: 10.1016/j.ijcchd.2021.100266. Epub 2021 Oct 28.
3
Risk stratification of adults with congenital heart disease during the COVID-19 pandemic: insights from a multinational survey among European experts.COVID-19 大流行期间成人先天性心脏病的风险分层：来自欧洲专家跨国调查的见解。
Open Heart. 2021 Apr;8(1). doi: 10.1136/openhrt-2020-001455.
4
Considerations for fair prioritization of COVID-19 vaccine and its mandate among healthcare personnel.医疗保健人员 COVID-19 疫苗公平优先排序及其授权的考虑因素。
Curr Med Res Opin. 2021 Jun;37(6):907-909. doi: 10.1080/03007995.2021.1908245. Epub 2021 Apr 9.
5
Morbidity and mortality in adults with congenital heart defects in the third and fourth life decade.第三和第四个生命十年期间患有先天性心脏病的成年人的发病率和死亡率。
Clin Res Cardiol. 2022 Aug;111(8):900-911. doi: 10.1007/s00392-022-01989-1. Epub 2022 Mar 1.
6
Pharmacological management of heart failure in adults with congenital heart disease.成人先天性心脏病心力衰竭的药物治疗。
Heart Fail Rev. 2024 Nov;29(6):1175-1185. doi: 10.1007/s10741-024-10428-4. Epub 2024 Aug 12.
7
Cardiovascular Prevention Among Young Adults with Congenital Heart Disease.先天性心脏病青年的心血管预防。
Curr Atheroscler Rep. 2022 Jul;24(7):509-514. doi: 10.1007/s11883-022-01034-6. Epub 2022 Apr 30.
8
PATHFINDER-CHD: prospective registry on adults with congenital heart disease, abnormal ventricular function, and/or heart failure as a foundation for establishing rehabilitative, prehabilitative, preventive, and health-promoting measures: rationale, aims, design and methods.PATHFINDER-CHD：先天性心脏病、心室功能异常和/或心力衰竭成人的前瞻性登记研究，为制定康复、预康复、预防和促进健康措施奠定基础：基本原理、目的、设计和方法。
BMC Cardiovasc Disord. 2024 Mar 26;24(1):181. doi: 10.1186/s12872-024-03833-y.
9
Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease.2019年冠状病毒病在成人先天性心脏病患者中的情况：欧洲心脏病学会成人先天性心脏病工作组及国际成人先天性心脏病学会的立场文件
Eur Heart J. 2021 May 14;42(19):1858-1865. doi: 10.1093/eurheartj/ehaa960.
10
Multi-Organ Transplantation in Adult Congenital Heart Disease: Navigating the Unique Challenges of a Distinct Patient Population.成人先天性心脏病的多器官移植：应对特殊患者群体的独特挑战
Methodist Debakey Cardiovasc J. 2025 May 15;21(3):72-82. doi: 10.14797/mdcvj.1576. eCollection 2025.
引用本文的文献
1
Comparison of COVID-19 Vaccine-Associated Myocarditis and Viral Myocarditis Pathology.新型冠状病毒肺炎疫苗相关心肌炎与病毒性心肌炎病理学比较
Vaccines (Basel). 2023 Feb 5;11(2):362. doi: 10.3390/vaccines11020362.
2
Optimizing COVID-19 vaccine allocation considering the target population.考虑目标人群优化 COVID-19 疫苗分配。
Front Public Health. 2023 Jan 6;10:1015133. doi: 10.3389/fpubh.2022.1015133. eCollection 2022.
3
COVID-19 vaccination in adults with congenital heart disease: Real-world data from an Italian tertiary centre.先天性心脏病成人的新冠病毒疫苗接种：来自意大利一家三级中心的真实世界数据。
Int J Cardiol Congenit Heart Dis. 2021 Dec;6:100266. doi: 10.1016/j.ijcchd.2021.100266. Epub 2021 Oct 28.
本文引用的文献
1
Anatomical complexity does not predict outcomes after COVID-19 in adults with congenital heart disease.
Heart. 2021 Jul 12;107(15):1193-1195. doi: 10.1136/heartjnl-2021-319054.
2
COVID-19 in Adults With Congenital Heart Disease.成人先天性心脏病患者中的 COVID-19。
J Am Coll Cardiol. 2021 Apr 6;77(13):1644-1655. doi: 10.1016/j.jacc.2021.02.023.
3
Clinical outcome of COVID-19 in patients with adult congenital heart disease.成人先天性心脏病患者感染新型冠状病毒肺炎的临床结局
Heart. 2021 Jul 12;107(15):1226-1232. doi: 10.1136/heartjnl-2020-318467.
4
ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization: A Report of the American College of Cardiology Solution Set Oversight Committee.美国心脏病学会关于2019冠状病毒病疫苗优先排序的心血管疾病考量的健康政策声明：美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2021 Apr 20;77(15):1938-1948. doi: 10.1016/j.jacc.2021.02.017. Epub 2021 Feb 12.
5
Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease.2019年冠状病毒病在成人先天性心脏病患者中的情况：欧洲心脏病学会成人先天性心脏病工作组及国际成人先天性心脏病学会的立场文件
Eur Heart J. 2021 May 14;42(19):1858-1865. doi: 10.1093/eurheartj/ehaa960.
6
Impact of COVID-19 on patients with congenital heart disease.新型冠状病毒肺炎对先天性心脏病患者的影响。
Cardiol Young. 2021 Jan;31(1):163-165. doi: 10.1017/S1047951120004345. Epub 2020 Dec 14.
7
Impact of Coronavirus Disease 2019 (COVID-19) on Patients With Congenital Heart Disease Across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York City.2019 年冠状病毒病（COVID-19）对全生命周期先天性心脏病患者的影响：纽约市一家学术先天性心脏病中心的经验。
J Am Heart Assoc. 2020 Dec;9(23):e017580. doi: 10.1161/JAHA.120.017580. Epub 2020 Oct 14.
8
Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis.心血管疾病与其他 10 种预先存在的合并症与 COVID-19 死亡率的关联：系统评价和荟萃分析。
PLoS One. 2020 Aug 26;15(8):e0238215. doi: 10.1371/journal.pone.0238215. eCollection 2020.
9
Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis.心血管风险特征对 COVID-19 结局的影响。一项荟萃分析。
PLoS One. 2020 Aug 14;15(8):e0237131. doi: 10.1371/journal.pone.0237131. eCollection 2020.
10
Coronavirus Disease 2019 Infection in Children with Pre-Existing Heart Disease.儿童先天性心脏病与 2019 年冠状病毒病感染。
J Pediatr. 2020 Dec;227:302-307.e2. doi: 10.1016/j.jpeds.2020.07.069. Epub 2020 Jul 27.
Zotero 插件